| Authors: |
Shakiba M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY., Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY., Espinosa-Carrasco G; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Menocal L; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Dündar F; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY., Carson SE; Department of Biochemistry, Cell and Molecular Biology, Weill Cornell Medicine, New York, NY., Bruno EM; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Sanchez-Rivera FJ; Cancer Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Lowe SW; Cancer Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Camara S; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY., Reuter VP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY., Socci ND; Bioinformatics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY., Whitlock B; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Tamzalit F; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Huse M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY., Hellmann MD; Parker Institute for Cancer Immunotherapy, San Francisco, CA.; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, Cornell University, New York, NY., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Defranoux NA; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Betel D; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY., Philip M; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN., Schietinger A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY. |
